Immuron Limited (IMRN:NASDAQ) jumped higher at $3.83, representing a gain of 49.6%. The stock got featured on our News Catalysts scanner on Wed, Jan 12, 2022 at 08:08 AM in the 'AGREEMENT' category. From Tue, Dec 28, 2021, the stock recorded 60.00% Up Days and 45.45% Green Days
The stock spiked on Fri, Sep 24, 2021 at $5.2 with a volume of 1M+.
About Immuron Limited (IMRN:NASDAQ)
Immuron Ltd is a biopharmaceutical company which develops polyclonal antibodies for the treatment and prevention of diseases. It products include Travelan, IMM-124E for NASH and IMM-529 for Clostridium difficile infection.
Top 10 Gainers:
- LF Capital Acquisition Corp. (LFAC:NASDAQ), 100%
- electroCore, Inc. (ECOR:NASDAQ), 64.03%
- Immuron Limited (IMRN:NASDAQ), 49.61%
- Nxt-ID, Inc. (NXTD:NASDAQ), 30.6%
- VAXX (VAXX:NASDAQ), 29.67%
- FATH (FATH:NYSE), 29%
- BBIG (BBIG:NASDAQ), 23.08%
- Pintec Technology Holdings Limited (PT:NASDAQ), 21.13%
- PIK (PIK:NASDAQ), 20.66%
- VINE (VINE:NYSEMKT), 19.93%